A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
about
Adjuvants: Classification, Modus Operandi, and LicensingMixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvantsViral Vaccines and CTL ResponseAn update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.MF59™ as a vaccine adjuvant: a review of safety and immunogenicity.Defined synthetic vaccines.Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.New adjuvants: EU regulatory developments.Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy.Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: a review of HEPLISAV™ safety and efficacy.Current adjuvants and new perspectives in vaccine formulation.Particulate inorganic adjuvants: recent developments and future outlook.Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis.European guideline for the management of hepatitis B and C virus infections.
P2860
Q26747586-4D9ED50F-565C-496D-AE16-4A7B94109526Q27304735-E33D8781-C2EC-4F64-8A04-CC9C052200D4Q27491330-6FC4749C-C9EE-468C-A64C-A1F975E77613Q30352329-E722DD37-B1BE-435E-975B-9D0A43709E0FQ30394545-22B08FC5-1139-4BD5-B1D2-FE0CE5C8F0C4Q34280941-B9E57EC9-7723-4065-8100-2B6301365BB1Q35953762-AD1E57AB-0153-496F-8070-E53647265EABQ36968305-017F0EAB-532B-40C7-BCDA-7DDC7130CFDDQ36981682-EEB1FE33-1624-419E-A93C-C9CCE4815560Q37812128-48D8EC50-563D-4FF0-99D6-C81188385303Q37837477-A2561ABA-55B7-4E2A-A063-6CD2A3B98E8AQ37867099-2C893512-963F-48BA-BE84-AF941E0639AAQ37909424-48822836-60C1-43E6-971A-EE0E2EE00E1BQ38286377-E012D4AD-3DBD-4F73-B05D-BCE699A73C3BQ43760309-472E40B5-2EAB-4EE3-8F96-93939D4E200BQ44118049-C90BE4F0-CE63-44EF-8A36-353283C6A80C
P2860
A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant
description
im Juli 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 July 1999
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 1999
@uk
name
A randomized, controlled study ...... ccine containing MF59 adjuvant
@en
A randomized, controlled study ...... ccine containing MF59 adjuvant
@nl
type
label
A randomized, controlled study ...... ccine containing MF59 adjuvant
@en
A randomized, controlled study ...... ccine containing MF59 adjuvant
@nl
prefLabel
A randomized, controlled study ...... ccine containing MF59 adjuvant
@en
A randomized, controlled study ...... ccine containing MF59 adjuvant
@nl
P2093
P1433
P1476
A randomized, controlled study ...... ccine containing MF59 adjuvant
@en
P2093
D Sakamoto
G A Poland
G A Van Nest
M L Clements-Mann
T C Heineman
P304
P356
10.1016/S0264-410X(99)00088-2
P407
P577
1999-07-01T00:00:00Z